Children with Smith-Lemli-Opitz syndrome (SLOS) are typically reported to have moderate to severe intellectual disability. This study aims to determine whether normal cognitive function is 
SLOS have moderate to severe intellectual disability. A strong correlation of biochemical parameters and severity score with development has been reported previously (Cunniff, Kratz, Moser, Natowicz, & Kelley 1997; Kratz and Kelley, 1999; Ryan et al., 1998; Sikora et al., 2004 ).
Normal to low-normal cognitive functioning in SLOS has been reported very rarely (Ryan et al., 1998; Mueller et al., 2003) . After identifying a child with average intelligence at OHSU, we collaborated with other centers to find additional subjects and aimed to describe the characteristics of SLOS subjects with normal cognitive function.
| METHODS
Our study included subjects with SLOS who have been followed at four and Wechsler Preschool and Primary Scale of Intelligence-3rd Edition (WPPSI-III) were used to measure cognitive functions of subjects.
| RESULTS
Nine subjects (6.2%) were identified with at least one composite IQ score above 80 among 145 subjects with SLOS (Table 1 ). The median age at diagnosis was 24 months (2 weeks-14 years). The median cholesterol level of subjects at diagnosis was 128 mg/dl (range: 85-181), median 7DHC level was 2.8 mg/dl (range: 2-5.2). Clinical severity scores were consistent with mild phenotype (range: 5-10).
No specific mutation patterns were observed. Subject 9, in addition, 
| DISCUSSION
SLOS is commonly reported as a multiple malformation/intellectual disability syndrome. However, intellectual disability appears to occur across a range, with mild intellectual disability with IQ of 50-70 previously detected in 1 in 10 children (Ryan et al., 1998; Kelley and Hennekam, 2000) . Current findings suggest that significant intellectual disability may not be universal in SLOS.
Factors determining variation in intellectual functioning in SLOS are unclear, though cholesterol's role in brain development and activity, as well as accumulation of potentially toxic cholesterol precursors, 7-DHC, and its isomer 8-DHC are implicated. Cholesterol is essential for brain development, myelination, neuronal signaling and survival (Orth and Bellosta, 2012) . It is also essential for processing and signaling of sonic hedgehog, a morphogen involved in midline development (Porter et al., 1996; Maity, Fuse, & Beachy, 2005; Stottmann et al., 2011) . Thus, severity of cholesterol depletion in the brain is expected to affect the degree of neuronal dysfunction and somatic malformations including brain abnormalities such as microcephaly, holoprosencephaly, and corpus callosum agenesis. In support of this, Lee, Conley, Gropman, Porter, and Baker (2013) found significant correlations between brain anomaly severity score and other measures of SLOS severity such as somatic severity score, 7-DHC and total cholesterol levels. Lee, Yoshida, et al. (2013) Cholesterol supply during embryogenesis is likely to be the most important factor affecting SLOS phenotype (Cunniff et al., 1997) .
Although most of the cholesterol is synthesized endogenously in the growing embryo (Pitkin, Connor, & Lin, 1972) , there is evidence that the fetus depends largely on maternal cholesterol, predominantly by transport of lipoproteins from the mother (Baardman et al., 2013 These studies show that modification of placental cholesterol transfer pathways may be an approach for prenatal therapy of SLOS.
Cholesterol supplementation is widely recommended for treatment of SLOS; however, cholesterol does not cross the blood-brain barrier (Dietschy and Turley, 2001 ), thus, does not improve developmental progress of affected individuals (Sikora et al., 2004) .
Statins, which do cross the blood-brain barrier, are being tested in SLOS (Haas et al., 2007) . Simvastatin has been shown to decrease 7-DHC levels and increase cholesterol in fibroblasts from patients with SLOS when there was at least some activity of 7DHCR (Wassif et al., 2005) . However, whether statins affects cognitive development remains unknown. Determining the factors affecting the SLOS phenotype could shed light on pathophysiology and potential therapeutic strategies.
The nine children identified in the current study had at least one IQ composite score in the normal or near normal range, with relative strengths in verbal and working memory abilities. However, they had other IQ composite standard scores below 80. Thus, many of these children have cognitive and learning impairments that likely necessitate attention in school and at home.
There are several limitations to the study. The sample size is relatively small (though large for such a rare disorder), limiting analysis of associations between cognitive profiles and other phenotypic and genotypic indicators;
however, SLOS is a rare disease and children with higher cognitive skills are more likely underdiagnosed. The IQ scores were obtained over a 10-year period and various IQ tests were utilized, resulting in possible influence of method variance and differences in interpretation. Longitudinal data are not available; therefore it is not known whether these children preserve their normal cognitive skills.
In conclusion, normal IQ is possible in children with SLOS and may be more prevalent than previously recognized. As physical findings in SLOS may be subtle and easily overlooked, these findings raise the Disclosures: The authors declare no conflicts of interest.
